These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37017883)

  • 1. Vancomycin Clearance in Obese Adults is not Predictive of Clearance in Obese Adolescents.
    Zhang T; Smit C; Sherwin CMT; Knibbe CAJ; Krekels EHJ
    Clin Pharmacokinet; 2023 May; 62(5):749-759. PubMed ID: 37017883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher Midazolam Clearance in Obese Adolescents Compared with Morbidly Obese Adults.
    van Rongen A; Brill MJE; Vaughns JD; Välitalo PAJ; van Dongen EPA; van Ramshorst B; Barrett JS; van den Anker JN; Knibbe CAJ
    Clin Pharmacokinet; 2018 May; 57(5):601-611. PubMed ID: 28785981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Metformin Clearance in Overweight and Obese Adolescents: A Pharmacokinetic Substudy of a Randomized Controlled Trial.
    van Rongen A; van der Aa MP; Matic M; van Schaik RHN; Deneer VHM; van der Vorst MM; Knibbe CAJ
    Paediatr Drugs; 2018 Aug; 20(4):365-374. PubMed ID: 29748932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosing Recommendations for Vancomycin in Children and Adolescents with Varying Levels of Obesity and Renal Dysfunction: a Population Pharmacokinetic Study in 1892 Children Aged 1-18 Years.
    Smit C; Goulooze SC; Brüggemann RJM; Sherwin CM; Knibbe CAJ
    AAPS J; 2021 Apr; 23(3):53. PubMed ID: 33839974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propofol clearance in morbidly obese children and adolescents: influence of age and body size.
    Diepstraten J; Chidambaran V; Sadhasivam S; Esslinger HR; Cox SL; Inge TH; Knibbe CA; Vinks AA
    Clin Pharmacokinet; 2012 Aug; 51(8):543-51. PubMed ID: 22690673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetics of midazolam and its metabolites in overweight and obese adolescents.
    van Rongen A; Vaughns JD; Moorthy GS; Barrett JS; Knibbe CA; van den Anker JN
    Br J Clin Pharmacol; 2015 Nov; 80(5):1185-96. PubMed ID: 26044579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian Estimation of Vancomycin Pharmacokinetics in Obese Children: Matched Case-Control Study.
    Le J; Capparelli EV; Wahid U; Wu YS; Romanowski GL; Tran TM; Nguyen A; Bradley JS
    Clin Ther; 2015 Jun; 37(6):1340-51. PubMed ID: 26031618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin trough concentrations in overweight or obese pediatric patients.
    Heble DE; McPherson C; Nelson MP; Hunstad DA
    Pharmacotherapy; 2013 Dec; 33(12):1273-7. PubMed ID: 23798327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric Obesity: Pharmacokinetic Alterations and Effects on Antimicrobial Dosing.
    Natale S; Bradley J; Nguyen WH; Tran T; Ny P; La K; Vivian E; Le J
    Pharmacotherapy; 2017 Mar; 37(3):361-378. PubMed ID: 28079262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic properties of infliximab in children and adults with Crohn's disease: a retrospective analysis of data from 2 phase III clinical trials.
    Fasanmade AA; Adedokun OJ; Blank M; Zhou H; Davis HM
    Clin Ther; 2011 Jul; 33(7):946-64. PubMed ID: 21741088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propofol Clearance in Morbidly Obese Children and Adolescents : Influence of Age and Body Size.
    Diepstraten J; Chidambaran V; Sadhasivam S; Esslinger HR; Cox SL; Inge TH; Knibbe CA; Vinks AA
    Clin Pharmacokinet; 2012 Aug; 51(8):543-551. PubMed ID: 28258392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin dosing in morbidly obese patients.
    Bauer LA; Black DJ; Lill JS
    Eur J Clin Pharmacol; 1998 Oct; 54(8):621-5. PubMed ID: 9860149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin dosing in healthy-weight, overweight, and obese pediatric patients.
    Eiland LS; Sonawane KB
    J Pediatr Pharmacol Ther; 2014 Jul; 19(3):182-8. PubMed ID: 25309148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determining vancomycin clearance in an overweight and obese population.
    Leong JV; Boro MS; Winter M
    Am J Health Syst Pharm; 2011 Apr; 68(7):599-603. PubMed ID: 21411801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Sex, Age, and Weight on Levetiracetam Pharmacokinetics.
    Alzueta N; Ortega A; Aldaz A
    Ther Drug Monit; 2018 Oct; 40(5):628-634. PubMed ID: 29965883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric Obesity: Pharmacokinetics and Implications for Drug Dosing.
    Kendrick JG; Carr RR; Ensom MH
    Clin Ther; 2015 Sep; 37(9):1897-923. PubMed ID: 26361823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glomerular hyperfiltration in excess weight adolescents.
    Iduoriyekemwen NJ; Ibadin MO; Aikhionbare HA; Idogun SE; Abiodun MT
    Niger J Clin Pract; 2019 Jun; 22(6):842-848. PubMed ID: 31187771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of overweight and obesity in the United States, 1999-2004.
    Ogden CL; Carroll MD; Curtin LR; McDowell MA; Tabak CJ; Flegal KM
    JAMA; 2006 Apr; 295(13):1549-55. PubMed ID: 16595758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin dosage in overweight and obese children.
    Miller M; Miller JL; Hagemann TM; Harrison D; Chavez-Bueno S; Johnson PN
    Am J Health Syst Pharm; 2011 Nov; 68(21):2062-8. PubMed ID: 22011985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lifestyle intervention for improving school achievement in overweight or obese children and adolescents.
    Martin A; Saunders DH; Shenkin SD; Sproule J
    Cochrane Database Syst Rev; 2014 Mar; (3):CD009728. PubMed ID: 24627300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.